BioSpace News Archive

Business

Biocept Appoints Philippe Marchand as Chief Operating Officer

Biocept, Inc has appointed Philippe Marchand, Ph.D., to the position of Chief Operating Officer, effective today.

March 8, 2022
·
4 min read
Biotech Beach

Representatives of Fulgent Genetics to Participate in Oppenheimer’s 32nd Annual Healthcare Conference

Fulgent Genetics, Inc. announced that members of its management team are scheduled to virtually participate in Oppenheimer’s 32nd Annual Healthcare Conference on Tuesday, March 15, 2022.

March 8, 2022
·
1 min read
Business

ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET

IMMUNOPRECISE ANTIBODIES LTD. today announced today announced that it will host a conference call to discuss its financial results and recent business highlights for third quarter fiscal year 2022, on Wednesday, March 16th, 2022, at 10:30 a.m. ET.

March 8, 2022
·
2 min read
Biotech Bay

Guardant Health Receives Medicare Coverage for Guardant360 TissueNext™ Test

Guardant Health, Inc., a leading precision oncology company, announced that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program, has conveyed coverage for Guardant360 TissueNext™ under the existing local coverage determination .

March 8, 2022
·
3 min read
Revance Resubmits Biologics License Application for DaxibotulinumtoxinA for Injection for Glabellar Lines to the FDA

Revance Therapeutics, Inc. today announced it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA.

March 8, 2022
·
5 min read
Business

BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo® (cemiplimab), a PD-1 inhibitor, in advanced non-small cell lung cancer (NSCLC).

March 8, 2022
·
6 min read
Business

Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results

Panbela Therapeutics, Inc. today announced that it will host a conference call on March 24, 2022 at 4:30 PM Eastern Time to discuss results for its fourth quarter ended December 31, 2021.

March 8, 2022
·
5 min read
Genetown

Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic

Yield10 Bioscience, Inc. today announced recent advances in the development of Camelina as a platform for the production of PHA bioplastic directly in the seed.

March 8, 2022
·
6 min read
Biotech Bay

BrightInsight and UCB Partner to Build Digital Care Solutions for Rare Diseases

BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with the global biopharmaceutical company, UCB, to develop and bring to market a digital disease management solution for patients with rare diseases.

March 8, 2022
·
3 min read
Genetown

Radius Health Provides Business Update on Bone Health

On December 15, 2020, Radius announced a discovery research collaboration with Massachusetts General Hospital to evaluate novel oral salt-inducible kinase inhibitors in an array of musculoskeletal diseases.

March 8, 2022
·
6 min read